Results 51 to 60 of about 105,429 (154)

Human papillomavirus persistence and clearance in women living with HIV: A five‐year retrospective analysis from an Italian university center

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2041-2047, October 2026.
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea, Dario Colacurci, Giorgia D'Apice, Laura Letizia Mazzarelli, Massimiliano Pellicano, Luigi Falco, Ginevra Sepe, Oriana Imperatore, Giuseppe Maria Maruotti, Maurizio Guida, Laura Sarno   +10 more
wiley   +1 more source

Extramammary Paget’s Disease of the Vulva and Concomitant Premalignant/Malignant Vulvar Lesions: A Potential Challenge in Diagnosis and Treatment

Current Oncology, 2023
The aim of the present study was to evaluate the incidence of concomitant vulvar cancers or premalignant lesions in women surgically treated for extramammary Paget’s disease of the vulva (EMPDV) through a multicenter case series.
Nicolò Clemente, Andrea Ciavattini, Gaetano Valenti, Federica Zannier, Jacopo Di Giuseppe, Giovanni Delli Carpini, Mariasole Fichera, Anna Del Fabro, Giorgio Giorda, Gaia Goteri, Vincenzo Canzonieri, Francesco Sopracordevole   +11 more
doaj   +1 more source

Active surveillance of cervical intraepithelial neoplasia and adverse pregnancy outcomes: A register‐based cohort study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2097-2103, October 2026.
Active surveillance for cervical intraepithelial neoplasia grade 2 is not associated with increased risks of adverse pregnancy outcomes compared to large loop excision of the transformation zone. Abstract Introduction Previous studies have suggested that human papillomavirus (HPV) and HPV‐related disease may be associated with increased risk of adverse
Kirstine Kold Katholm, Lotte Krog Eriksen, Kathrine Dyhr Lycke, Ninna Lund Larsen, Iben Sundtoft, Tina Hovgaard Randrup, Anne Hammer   +6 more
wiley   +1 more source

HPV infection and intraepithelial lesions from the anal region: how to diagnose?

Brazilian Journal of Infectious Diseases
In the last years, the prevalence of HPV infection in the anal region has increased, especially in some groups like homosexual and HIV-positive people.
Newton Sérgio de Carvalho, Aliana Meneses Ferreira, Camila Caroline Tremel Bueno   +2 more
doaj   +1 more source

Economic burden of vulvar and vaginal intraepithelial neoplasia: retrospective cost study at a German dysplasia centre

BMC Infectious Diseases, 2011
Background Human papillomavirus is responsible for a variety of diseases including grade 2 and 3 vulvar and vaginal intraepithelial neoplasia. The aim of this study was to assess parts of the burden of the last diseases including treatment costs.
Kok Patrick, Schulz-Holstege Olaf, Huppertz Eduard, Hampl Monika, Schmitter Sarah   +4 more
doaj   +1 more source

Long‐term outcome of ablation for anal HSIL: Achieving HSIL‐free status is key—A UK‐based retrospective cohort study

Colorectal Disease, Volume 28, Issue 9, September 2026.
Abstract Introduction Treating anal high‐grade squamous intraepithelial lesions (HSIL) reduces squamous cell carcinoma (SCC) rates in high‐risk groups such as men having sex with men (MSM), especially those living with HIV (LWH). Follow‐up data after HSIL treatment is lacking.
T. Cuming, K. Rozemeijer, E. Farrow, C. Cappello, B. Wait, M. Junejo, J. Bowring, A. N. Rosenthal, O. Richel, M. Nathan, H. J. C. de Vries, J. M. Prins   +11 more
wiley   +1 more source

Vulvar intraepithelial neoplasia [PDF]

, 2003
In order to improve the timely diagnostics and the efficacy of treatment of vulvar intraepithelial neoplasia, vulvar intraepithelial neoplasia diagnostics criteria and the modern treatment strategies are discussed in this review.
Čigriejienė, Vida Marija, Žilinskas, Kastytis, Sakalienė, Jurgita   +2 more
core  

The eight-year long-term follow-up on the effectiveness of the quadrivalent human papillomavirus vaccine in Chinese women 20-45 years of age

Human Vaccines & Immunotherapeutics, 2022
The quadrivalent human papillomavirus (4vHPV) vaccine has shown confirmative effectiveness in preventing HPV-related diseases among women and men around the globe. The phase III, randomized, double-blind efficacy study (Base study, NCT00834106) conducted
Chao Zhao, Yun Zhao, Jingran Li, Mingzhu Li, Yanyan Su, Xin Mi, Su Yi La Tu, Danhua Shen, Lihua Ren, Yanyan Li, Linhong Wang, Lihui Wei   +11 more
doaj   +1 more source

Vulvar Diseases that Required a Biopsy: A Retrospective Study

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2021
Introduction: The vulvar area may be affected by many noninfectious conditions with similar clinical appearance, requiring a cutaneous biopsy. Our goal was to characterize the noninfectious vulvar diseases that required a biopsy in a southwestern Europe ...
Rita Bouceiro-Mendes, M. Mendonça-Sanches, Luís Soares-de-Almeida, Isabel Correia-Fonseca, João Borges-da-Costa   +4 more
doaj   +1 more source

Risk stratification and anal cancer screening in immunocompetent women with genital HPV: Value of multicentric HSIL and performance of HPV‐based screening

International Journal of Cancer, Volume 159, Issue 4, Page 1017-1027, 15 August 2026.
What's new? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas, Aureli Torné, Adela Saco, Cristina Martí, Ada Cardiel, Natalia Rakislova, Lorena Marimon, Ariel Glickman, Ingrid Victoria, Silvia Alós, Jesús Lopez‐Diaz, Pere Fusté, Jaume Ordi, Marta del Pino   +13 more
wiley   +1 more source